Maharashtra records 1,881 COVID-19 cases, 81% rise; no death

PTI

June 07, 2022 / 20:57 IST

(Image: Reuters)

Maharashtra on Tuesday recorded 1,881 new coronavirus cases, 81 per cent more than the previous day and highest since February 18, and also reported one case of B.A.5 variant, the state health department said.

State capital Mumbai alone accounted for 1,242 new cases, almost double the Monday's count.No new pandemic-related death was reported during the day.

On Monday, the state had recorded 1,036 infections while Mumbai had reported 676 cases. It may be noted that generally fewer cases are recorded on Mondays as fewer tests are carried out during weekends.On Tuesday, Maharashtra's COVID-19 case tally rose to 78,96,114, while the death toll remained unchanged at 1,47,866.

Tuesday's daily rise in cases was highest since February 18 when the state had recorded 2,086 new cases. As per the latest report of `whole genomic sequencing' from BJ Medical College, Pune, a 31-year-old woman from Pune was found positive for B.A.5 variant, the official release said.

"The woman was asymptomatic and recovered in home isolation," the release added.On May 28, for the first time in Maharashtra four patients of B.A.4 sub-lineage and three cases of B.A.5 sub-lineage of the Omicron variant of coronavirus were found.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show